Cargando…

Critical illness hyperglycemia: is failure of the beta-cell to meet extreme insulin demand indicative of dysfunction?

In the recent study by Preissig and Rigby in Critical Care, the authors argue that critical illness hyperglycemia in children with both respiratory failure and cardiovascular failure is due to a primary failure of the beta-cell. However, alternative explanations that the failure is secondary to an i...

Descripción completa

Detalles Bibliográficos
Autores principales: Steil, Garry M, Agus, Michael SD
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689480/
https://www.ncbi.nlm.nih.gov/pubmed/19435475
http://dx.doi.org/10.1186/cc7756
_version_ 1782167800885805056
author Steil, Garry M
Agus, Michael SD
author_facet Steil, Garry M
Agus, Michael SD
author_sort Steil, Garry M
collection PubMed
description In the recent study by Preissig and Rigby in Critical Care, the authors argue that critical illness hyperglycemia in children with both respiratory failure and cardiovascular failure is due to a primary failure of the beta-cell. However, alternative explanations that the failure is secondary to an increase in insulin resistance leading to beta-cell exhaustion, or a negative impact of exogenous glucocorticoid therapy, may be equally likely.
format Text
id pubmed-2689480
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26894802010-04-03 Critical illness hyperglycemia: is failure of the beta-cell to meet extreme insulin demand indicative of dysfunction? Steil, Garry M Agus, Michael SD Crit Care Commentary In the recent study by Preissig and Rigby in Critical Care, the authors argue that critical illness hyperglycemia in children with both respiratory failure and cardiovascular failure is due to a primary failure of the beta-cell. However, alternative explanations that the failure is secondary to an increase in insulin resistance leading to beta-cell exhaustion, or a negative impact of exogenous glucocorticoid therapy, may be equally likely. BioMed Central 2009 2009-04-03 /pmc/articles/PMC2689480/ /pubmed/19435475 http://dx.doi.org/10.1186/cc7756 Text en Copyright © 2009 BioMed Central Ltd
spellingShingle Commentary
Steil, Garry M
Agus, Michael SD
Critical illness hyperglycemia: is failure of the beta-cell to meet extreme insulin demand indicative of dysfunction?
title Critical illness hyperglycemia: is failure of the beta-cell to meet extreme insulin demand indicative of dysfunction?
title_full Critical illness hyperglycemia: is failure of the beta-cell to meet extreme insulin demand indicative of dysfunction?
title_fullStr Critical illness hyperglycemia: is failure of the beta-cell to meet extreme insulin demand indicative of dysfunction?
title_full_unstemmed Critical illness hyperglycemia: is failure of the beta-cell to meet extreme insulin demand indicative of dysfunction?
title_short Critical illness hyperglycemia: is failure of the beta-cell to meet extreme insulin demand indicative of dysfunction?
title_sort critical illness hyperglycemia: is failure of the beta-cell to meet extreme insulin demand indicative of dysfunction?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689480/
https://www.ncbi.nlm.nih.gov/pubmed/19435475
http://dx.doi.org/10.1186/cc7756
work_keys_str_mv AT steilgarrym criticalillnesshyperglycemiaisfailureofthebetacelltomeetextremeinsulindemandindicativeofdysfunction
AT agusmichaelsd criticalillnesshyperglycemiaisfailureofthebetacelltomeetextremeinsulindemandindicativeofdysfunction